INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

Clinical trial NCT06314282 · RECRUITING

Trial details

NCT number: NCT06314282
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Systemic Lupus Erythematosus (SLE)

Start date: 2024-10-22
Primary completion: 2027-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.